Financials
Income statement
Fiscal date | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
---|---|---|---|---|
Total reported revenue | 5.2T | 4.0T | 4.1T | 5.0T |
Cost of revenue | 3.4T | 2.9T | 2.9T | 3.3T |
Gross profit | 1.8T | 1.1T | 1.2T | 1.8T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 720.9B | 579.6B | 606.6B | 785.8B |
Other operating expenses | 3.7B | 3.1B | 4.0B | -13.1B |
Operating income | 797.6B | 249.5B | 313.9B | 776.3B |
Non operating interest income | ||||
Income | 26.8B | 26.0B | 32.5B | 47.2B |
Expense | 46.5B | 44.1B | 48.1B | 22.4B |
Other income expense | — | — | — | — |
Pretax income | 786.8B | 245.1B | 298.0B | 792.5B |
Tax provision | 165.6B | 48.5B | 60.0B | 109.5B |
Net income | 621.2B | 196.7B | 238.0B | 683.0B |
Basic EPS | — | — | 69.4 | — |
Diluted EPS | — | — | 69.4 | — |
Basic average shares | — | — | 3.4B | — |
Diluted average shares | — | — | 3.4B | — |
EBITDA | 898.3B | 354.2B | 411.4B | 874.4B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |